Jan. 23, 2025 /Mpelembe Media/ — A Finnish research project, part of the European ITEA PROFIT initiative, explores using artificial intelligence to alleviate the workload of nurses. The project aims to develop AI tools for tasks like patient registration and information review, freeing up nurses for direct patient care. Continue reading
Jan. 14, 2025 /Mpelembe Media/ — BAIBYS™, an Israeli startup, announced its CE-marked AI-powered robotic system for autonomous sperm selection in IVF. This system uses AI and machine vision to identify and isolate optimal sperm cells, addressing the growing global issue of male infertility. Continue reading
Jan. 6, 2025 /Mpelembe Media/ — , a medical technology company, is partnering with the Mayo Clinic to pilot its Nevisense device in the US. Nevisense, an FDA-approved AI-powered tool, aids in the early detection of melanoma, the deadliest form of skin cancer. Continue reading
Jan. 3, 2025 /Mpelembe Media/ — The Surgeon General of the U.S. has called for cancer warnings on alcoholic beverages, citing studies linking alcohol consumption to at least seven types of cancer. A recent review of research supports this, showing a correlation between higher alcohol intake and increased cancer risk, particularly breast cancer. Continue reading
Jan. 3, 2025 /Mpelembe Media/ — Oncolytics Biotech Inc.’s progress in developing cutting-edge immunotherapies for cancer treatment is the article’s main subject. The piece highlights several key advancements, including clinical trial results and collaborations with other companies. Financial information regarding Oncolytics is included, along with a disclaimer about the nature of the publication. Continue reading
Diseases are best fought when those in the high-risk bracket understand as to what are the risk factors involved. It is true that you cannot avoid the genetic factor but you can still keep the situation in your control by making a few changes in your current approach to life and living. Continue reading
ONE® Flex® Condoms, the world’s first condom enhanced with the wonder material graphene, is now available at select Walmart stores and Walmart.com. Building on its online sales success since its market debut in October 2023, ONE Flex is further expanding its reach by bringing this revolutionary condom technology to Walmart shoppers. Continue reading
A live survey conducted during the “European Health Check” revealed that 77% of participants do not believe the current systemic framework applied to the generics industry is sustainable or effectively ensures the availability and accessibility of medicines for patients across the EU. This eye-opening result underscores the critical need for systemic reforms to support the generics industry, which is fundamental to delivering affordable and accessible healthcare in Europe. Continue reading
Orbis International announces new research that finds telemedicine can improve care for children with retinoblastoma, a form of childhood cancer that can lead to blindness. The study, published in JCO Global Oncology, is the first to show that virtual mentor-mentee relationships through Cybersight, Orbis’s free telemedicine and e-learning platform, not only improves lives, but can save them by successfully transferring skills to eye care professionals in low- and middle-income countries. Continue reading
After the fall of the al-Assad regime in Syria, large stockpiles of the illicit drug captagon have reportedly been uncovered.